Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker Study Assessing the Effects of Colchicine on Inflammation and Extra-Cellular Matrix Turnover in Patients With Heart Failure and Preserved Ejection Fraction.

NCT04857931 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT04857931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04857931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker Study Assessing the Effects of Colchicine on Inflammation and Extra-Cellular Matrix Turnover in Patients With Heart Failure and Preserved Ejection Fraction.
Lead sponsor
Montreal Heart Institute
Phase
Phase 2
Overall status
Terminated
Start date
June 17, 2022
Completion date
March 7, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colchicine, heart failure, inflammation